The Travere Therapeutics, Inc. Data Breach: Reported Filing Facts
Travere Therapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of therapies for rare diseases, placing it within the healthcare and life sciences sector. Given the nature of its business, the company likely maintains sensitive patient records, clinical trial data, and health-related information, which are subject to stringent privacy protections. This data breach was officially reported to the New Hampshire Attorney General in 2025, triggering formal disclosure requirements. If you have received a data breach notification letter from the company, it indicates that your personal or protected health information may have been involved in this security incident. We recommend reviewing the letter carefully to understand the specific scope of the exposure and the identity protection services being offered to affected individuals.
- State
- New Hampshire
- Reported
- October 27, 2025
What to do if you were affected
These general steps can help limit the risk of identity theft and fraud after any data breach.
Stay alert to targeted scams
Be cautious of calls, texts, or emails that reference this breach. Legitimate organizations won't ask you to confirm sensitive details through an unsolicited message.
Keep your notification letter
Save the notice you received. It documents that your information was involved and is often needed to enroll in any credit monitoring offered or to join a related legal claim.
Related data breach cases
- Janome America, Inc.
- Sullivan Environmental Services
- City of New Britain, Inc.
- New Hampshire Housing Yardi’s RentCafe
- Pocket FM
- Werth Wealth Management, LLC
- Wei Wei & Company
- Ameriprise Financial
- Joyal Financial Management Group
- Quantum Health
- HCA Healthcare, Inc.
- Alabama Symphonic Association Inc.
- Tombigbee Healthcare Authority dba Whitfield Regional Hospital
- Foster & Eldridge LLP